Showing results (91-100 of 125) with videos related to
Sort By:
Pageof 13
Der Internist|May 20, 2016
["Choosing wisely" in infectious diseases : Overuse of antibiotics - too few vaccinations]N Jung, H Koop, R Riessen, et al.Human Gene Therapy|December 1, 1993
Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloonR Riessen, H Rahimizadeh, E Blessing, et al.Journal of Molecular and Cellular Cardiology|February 28, 1998
Growth factor expression of human arterial smooth muscle cells and endothelial cells in a transfilter coculture systemD I Axel, R Riessen, A Athanasiadis, et al.Medizinische Klinik, Intensivmedizin Und Notfallmedizin|June 18, 2017
[Cost analysis as a tool for assessing the efficacy of intensive care units]T Maierhofer, F Pfisterer, A Bender, et al.Medizinische Klinik, Intensivmedizin Und Notfallmedizin|October 27, 2015
[Quality assurance concepts in intensive care medicine]A Brinkmann, J P Braun, R Riessen, et al.Journal of Vascular Research|August 31, 2000
Toxicity, uptake kinetics and efficacy of new transfection reagents: increase of oligonucleotide uptakeD I Axel, I Spyridopoulos, R Riessen, et al.The American Journal of Pathology|May 1, 1994
Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteriesR Riessen, J M Isner, E Blessing, et al.Der Anaesthesist|February 1, 1994
[Fulminating E. coli sepsis in Fournier's gangrene]S Zielmann, K Thies, M Sydow, et al.European Journal of Clinical Investigation|May 6, 1998
Effects of anti-C5a monoclonal antibodies on oxygen use in a porcine model of severe sepsisM Mohr, U Höpken, M Oppermann, et al.Basic Research in Cardiology|October 30, 1999
Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cellsR Riessen, D I Axel, M Fenchel, et al.Pageof 13